Skip to content
OpenCapital
Get started

Anika Therapeutics ANIK Payment, Tax Withholding, Share-Based Payment Arrangement

Payment, Tax Withholding, Share-Based Payment Arrangement at other companies

Globus Medical logo
Globus MedicalGMED
——
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
——

Other financials

Income statement

See full
Revenue$32.6M+15.6%
Net income$3.3M+183%
EPS (diluted)$0.24—

Balance sheet

See full
Cash & equivalents$38.4M-27.8%
Total debt$25.7M+1.2%
Total equity$137.3M-7.0%
Total assets$183.5M-2.2%

Cash flow

See full
Operating cash flow-$684.0K-262%
CapEx$1.4M-1.2%
Free cash flow-$2.1M-28.8%

Valuation

See full
Market cap$199.85M+23.0%
P/S1.7×-0.1×

Profitability

See full
Net margin-3.4%-1.6pp
FCF margin0.5%—

Returns & leverage

See full
Return on equity-2.9%-1.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.7×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Anika Therapeutics’s 8-K, filed July 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's payment, tax withholding, share-based payment arrangement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's payment, tax withholding, share-based payment arrangement?
Anika Therapeutics (ANIK) reported payment, tax withholding, share-based payment arrangement of $58K in Q2 2026.
How has Anika Therapeutics's payment, tax withholding, share-based payment arrangement changed year-over-year?
Anika Therapeutics's payment, tax withholding, share-based payment arrangement decreased by 29.3% year-over-year, from $82K to $58K.
What is the long-term trend for Anika Therapeutics's payment, tax withholding, share-based payment arrangement?
Over 4 years (2021 to 2025), Anika Therapeutics's payment, tax withholding, share-based payment arrangement has grown at a 34.0% compound annual growth rate (CAGR), from $486K to $1.57M.